Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study

BACKGROUND/AIMS: This study compared the efficacy of multimatrix mesalazine 2.4 g/day and 4.8 g/day with controlled-release mesalazine 2.25 g/day. METHODS: In this multicenter, randomized, double-blind study, 251 patients with mildly to moderately active ulcerative colitis received multimatrix mesal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Haruhiko, Yokoyama, Tadashi, Mizushima, Seiichi, Hagino, Atsushi, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934598/
https://www.ncbi.nlm.nih.gov/pubmed/29743838
http://dx.doi.org/10.5217/ir.2018.16.2.255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934598/
https://www.ncbi.nlm.nih.gov/pubmed/29743838
http://dx.doi.org/10.5217/ir.2018.16.2.255

Ejemplares similares